Celiac Disease Drug Market Size, Share, and Industry Analysis by Drug Class (NSAIDs, Corticosteroids, TNF-? Inhibitors, and Others), By Disease Type (Classical, Non-Classical, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content:

1. Introduction
   1. Research Scope
   2. Market Segmentation
   3. Research Methodology
   4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   1. Market Drivers
   2. Market Restraints
   3. Market Opportunities
   4. Market Trends
4. Key Insights
   1. Prevalence of Celiac Disease, By Key Countries, 2023
   2. New Product Launches, By Key Players
   3. Pipeline Analysis, By Key Players
   4. Key Industry Development (Mergers, Acquisitions, & Partnerships, etc.)
   5. Impact of COVID-19 on the Market
5. Global Celiac Disease Drug Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. Corticosteroids
      3. TNF-α Inhibitors
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Type
      1. Classical
      2. Non-classical
      3. Others
   3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
   5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
6. North America Celiac Disease Drug Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. Corticosteroids
      3. TNF-α Inhibitors
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Type
      1. Classical
      2. Non-classical
      3. Others
   3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
   5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
7. Europe Celiac Disease Drug Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. Corticosteroids
      3. TNF-α Inhibitors
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Type
      1. Classical
      2. Non-classical
      3. Others
   3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
   5. Market Analysis, Insights and Forecast – By County/Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
8. Asia Pacific Celiac Disease Drug Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. Corticosteroids
      3. TNF-α Inhibitors
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Type
      1. Classical
      2. Non-classical
      3. Others
   3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
   5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
9. Latin America Celiac Disease Drug Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug Class
      1. NSAIDs
      2. Corticosteroids
      3. TNF-α Inhibitors
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Type
      1. Classical
      2. Non-classical
      3. Others
   3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
   5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
10. Middle East & Africa Celiac Disease Drug Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
       1. NSAIDs
       2. Corticosteroids
       3. TNF-α Inhibitors
       4. Others
    2. Market Analysis, Insights and Forecast – By Disease Type
       1. Classical
       2. Non-classical
       3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
       1. Oral
       2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
       1. Hospital Pharmacies
       2. Drug Stores & Retail Pharmacies
       3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
       1. South Africa
       2. GCC
       3. Rest of Middle East & Africa
11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
       1. Takeda Pharmaceutical Company Limited
          1. Overview
          2. Services
          3. Financials (Based on Availability)
          4. Recent Developments
          5. Strategies
          6. SWOT,Etc.
       2. Dr. Falk Pharma GmbH
          1. Overview
          2. Services
          3. Financials (Based on Availability)
          4. Recent Developments
          5. Strategies
          6. SWOT,Etc.
       3. Entero Therapeutics, Inc.
          1. Overview
          2. Services
          3. Financials (Based on Availability)
          4. Recent Developments
          5. Strategies
          6. SWOT,Etc.
       4. ZEDIRA GmbH
          1. Overview
          2. Services
          3. Financials (Based on Availability)
          4. Recent Developments
          5. Strategies
          6. SWOT,Etc.
       5. Immunic Therapeutics
          1. Overview
          2. Services
          3. Financials (Based on Availability)
          4. Recent Developments
          5. Strategies
          6. SWOT,Etc.
       6. Nemysis Ltd
          1. Overview
          2. Services
          3. Financials (Based on Availability)
          4. Recent Developments
          5. Strategies
          6. SWOT,Etc.
       7. Anokion SA
          1. Overview
          2. Services
          3. Financials (Based on Availability)
          4. Recent Developments
          5. Strategies
          6. SWOT,Etc.
       8. Topas Therapeutics
          1. Overview
          2. Services
          3. Financials (Based on Availability)
          4. Recent Developments
          5. Strategies
          6. SWOT,Etc.
       9. Allero Therapeutics B.V.
          1. Overview
          2. Services
          3. Financials (Based on Availability)
          4. Recent Developments
          5. Strategies
          6. SWOT,Etc.
       10. Other Prominent Players  
           1. Overview
           2. Services
           3. Financials (Based on Availability)
           4. Recent Developments
           5. Strategies
           6. SWOT,Etc.